Navigation Links
Kettering Health Network Partners With DIATHERIX Laboratories To Improve Quality, Efficiency of Care
Date:3/15/2010

KETTERING, Ohio, March 15 /PRNewswire/ -- Kettering Health Network is the nation's first health system to use a new testing process developed by DIATHERIX Laboratories (www.DIATHERIX.com), which dramatically reduces the time it takes to detect H1N1, methicillin resistant staphylococcus (MRSA), Clostridium difficile (C-diff) and other infectious diseases. Kettering Medical Center (KMC) will be the first hospital in the network to use the testing system and DIATHERIX will maintain an onsite lab at the facility.

The method known as Target-Enriched Multiplex Polymerase Chain Reaction (TEM-PCR), licensed for use by Huntsville, Alabama-based DIATHERIX, allows microbiologists to test simultaneously for multiple pathogens from one specimen. The test takes approximately six hours to perform, compared to the conventional technology which takes a minimum of 48 hours. Rapid results improve care by reducing the rate of healthcare-associated infections due to multi-drug resistant organisms.

While it improves care, TEM-PCR is also a money saver because it allows healthcare workers to appropriately isolate patients with communicable diseases in a timely fashion. Projected savings for MRSA alone is about $225,000 a year at KMC alone. Cost savings will occur with other infectious diseases as well, and these savings will be realized at all Kettering Health Network hospitals and at other hospitals throughout the Dayton region. Thus, savings can easily be projected into the millions.

Additional savings will be realized by freeing up beds and by more efficient use of personnel and supplies. "When the possibility exists that a patient has H1N1 or MRSA, for example, he is immediately isolated until the disease can be ruled in or out. This means the patient cannot share a room with another patient. Therefore, the second bed in a two-person room is not utilized," said Carol Quinter, Ph.D., Laboratory Technical Director and Coordinator of Clinical Studies.

"Every time someone enters the room of an isolated patient, he must gown up and glove up and sometimes use special masks," Dr. Quinter added. "All of this is very time-consuming, expensive, and underutilizes the hospital's bed capacity. Technology which allows us to rule out the need for isolation in a timely manner is invaluable."

Beyond the obvious business benefits, the reduction in morbidity and mortality through TEM-PCR are expected to be significant nationwide. Hospital-associated infections cause an estimated 48,000 deaths a year in America. "Kettering Health Network is the first hospital system to partner with DIATHERIX, which places them at the forefront of technology that will decrease healthcare costs while enhancing patient care," said Dennis Grimaud, Chairman and CEO DIATHERIX, Inc. "Kettering has proven that they are focused on bringing new innovation to their hospital system, their physicians and patients within their community."

"Based on published studies, active surveillance reduces hospital acquired MRSA infections by as much as 50 percent.  We think you will see many more hospital affiliations with this company in the years to come," said Greg Wise, MD, Vice President for Medical Affairs for Kettering Medical Center.

The recent H1N1 pandemic points up the need for prompt diagnosis, isolation and treatment for such pathogens. "Identifying the organism is vital to making an accurate diagnosis," said Catherine Bacheller, MD, Medical Director of Infection Prevention and Control. "Illnesses caused by resistant bacteria can be treated more quickly and aggressively, with better outcome for the patient and less potential for the spread of infection to others."

DIATHERIX Laboratories, Inc. is located in the HudsonAlpha Institute for Biotechnology in Huntsville, Ala.  DIATHERIX operates as an independent high complexity CLIA-certified clinical laboratory providing advanced molecular multiplex diagnostic services to assist healthcare providers in the detection of infectious disease. For more information, please visit the company's web site at www.DIATHERIX.com.

Kettering Medical Center features some of the most advanced medical imaging practices in the country along with robotic surgery, Gamma Knife and other high technologies. KMC is one of six hospitals within Kettering Health Network, which serves an 11-county area in western Ohio. This past September a Thomson-Reuters study named KHN one of America's Top 10 Health Systems, based on the efficient delivery of quality care. The medical center and the network are named for Charles F. Kettering, the renowned inventor, and both institutions constantly strive to uphold his legacy of innovation.

SOURCE DIATHERIX

Back to top

RELATED LINKS
http://www.DIATHERIX.com

'/>"/>

SOURCE DIATHERIX
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center
2. MabVax Therapeutics Closes Two Licensing Agreements With Sloan-Kettering Institute for Cancer Research
3. FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis
4. Kantar Health CEO to Participate in Panel Discussion at PMRG 2010 Annual National Conference
5. CVS Caremark to Present at the Barclays Capital 2010 Global Healthcare Conference
6. Cornerstone Therapeutics to Present at the 30th Annual Cowen & Company Health Care Conference
7. U.S. Surgeon General Dr. Regina M. Benjamin to Deliver Commencement Address at Albany College of Pharmacy and Health Sciences
8. Limited Healthcare Infrastructure and Weak Intellectual Property Protection are Among the Challenges Pharma Faces with Emerging Market Expansion
9. Kantar Health Oncology Thought Leaders to Present at Upcoming Industry Meetings
10. Feintuch Communications Launches Integrated PR and IR Practice for Healthcare and Life Sciences Organizations
11. Genomic Health Announces Publication of Study Using Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated With Aromatase Inhibitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017 FinancialBuzz.com News ... According to ... was worth an estimated $6.6 billion in 2016, and is projected ... or reaching more than $24 billion by 2025. The medical cannabis ... growing from $4.7 billion in 2016, to an estimated $13.3 billion ...
(Date:3/22/2017)... 2017 EMD Serono, the biopharmaceutical business of Merck ... and Canada , today announced two new ... session at the 65 th Annual Pacific Coast Reproductive ... on March 24 th .   The results ... collected from July 2009 to December 2015 containing data from ...
(Date:3/22/2017)... MarketNewsUpdates.com News Commentary  ... As ... oil continues to rise in popularity with consumers, Cannabis ... enhancing production through acquiring innovative assets and other plant ... include: Future Farm Technologies Inc (OTC: FFRMF) (CSE: FFT.CN), mCig, ...
Breaking Medicine Technology:
(Date:3/22/2017)... CT (PRWEB) , ... March 22, 2017 , ... ... historic plan to cure Rett Syndrome, a devastating neurological disorder that afflicts 350,000 ... MECP2, located on the X chromosome, and almost exclusively strikes females. Following ...
(Date:3/22/2017)... ... 22, 2017 , ... Drs. Jennifer Houck, Lauren Smith, Heather Johnson and the ... in need of skilled pediatric dentistry in Rock Hill, SC, without a ... routine treatments, including cavities, sealants and fluoride applications, in a comfortable and fun environment. ...
(Date:3/22/2017)... York (PRWEB) , ... March 22, 2017 , ... ... Hospital have entered into a research collaboration to translate advances in basic neuroscience ... impairments at Blythedale and beyond. The collaboration seeks to improve movement, vision, and cognition ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... imaging core lab with extensive therapeutic experience and operational excellence in oncology clinical ... immuno-oncology clinical trial for the treatment of non-small cell lung cancer and small ...
(Date:3/22/2017)... ... March 22, 2017 , ... SNL Insurance ... to families and business owners in the greater Hampton Roads area, is embarking ... Society Relay For Life event. , Each year, hundreds of people living in ...
Breaking Medicine News(10 mins):